Members
-
Embryonic stem cells, induced pluripotent stem cells
-
Naive and Primed Pluripotency
-
Artificial embryo, Blastoid
-
Disease modeling for genetic disorder research
-
In vivo gene/cell therapy
-
Distinctive characteristic of ferroptosis in stem cells
-
Molecular mechanism of liver regeneration
-
Epigenetic regulation upon cellular dedifferentiation
-
Development of regenerative medicine
-
Disease modeling and drug discovery by using gene editing tools with PSCs.
-
Finding a new therapeutic strategy for genetic disease.
-
DNA damage repair and Cas9 gene editing
-
Embryonic stem cells, induced pluripotent stem cells
-
Naive and Primed Pluripotency
-
Artificial embryo, Blastoid
-
Epigenetic regulation during early embryogenesis
-
First lineage specification
-
Embryology
-
Totipotent/pluripotent stem cell
-
Molecular mechanism of liver regeneration
-
Epigenetic regulation upon cellular dedifferentiation
-
Development of regenerative medicine
-
Cell and gene therapy
-
Disease modeling
-
Exploring the world of science...
-
Mechanisms of Liver Reprogramming in Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
-
In Vivo Tumor Microenvironment Modeling Using Stem Cell–Derived Teratomas
-
In vivo reprogramming in stomach and molecular mechanism of gastric regeneration
-
Disease modeling and gene therapy
-
In vivo reprogramming in bone marrow and HSCs
-
Immune modulation during partial reprogramming
-
Blood epigenetic clock reversal by hematopoietic reprogramming
-
Exploring the world of science...
-
Exploring the world of science...
-
Site-specific large gene insertion
-
Gene editing tool development
-
RNA editing
